Navigation Links
$6.5 Million Grant for Microarray Center at Yale School of Medicine

In 1909, while harvesting a typical corn crop (Zea mays) in Illinois, a field worker noticed a plant so unusual that it was initially believed to be a new species. Its "peculiarly shaped ear" was "laid aside as a curiosity" and the specimen was designated Zea ramosa (from the Latin ramosus, "having many branches"). Due to the alteration of a single gene, later named ramosa1, both the ear and the tassel of the plant were more highly branched than usual, leading to loose, crooked kernel rows and to a tassel that was far bushier than the tops of normal corn plants.

Now, researchers at Cold Spring Harbor Laboratory in New York have isolated the ramosa1 gene and shown how it controls the arrangement and length of flower-bearing branches in corn, related cereal crops, and ornamental grasses. The study indicates that during the domestication of corn from its wild ancestor (teosinte), early farmers selected plants with special versions of the ramosa1 gene that suppressed branching in the ear, leading to the straight rows of kernels and the compact ears of modern-day corn on the cob. The findings are described in the July 24 advance online edition of the journal Nature.

"We've shown that corn and related grasses have either none, some, or a lot of ramosa1 gene activity, and that these different levels of activity have a big impact on the architecture of the plants," says Dr. Robert Martienssen of Cold Spring Harbor Laboratory, who led the study. "The ramosa1 gene appears to be a key player in the domestication of corn, and we've shown that it acts by signaling cells to form short rather than long branches," says Martienssen, who was joined in the study by lead author Dr. Erik Vollbrecht, now at Iowa State University.

Says Vollbrecht, "We solved this enduring puzzle by combining classical and modern molecular genetics. The former included our use of transposable elements or 'jumping genes'--discovered at Cold Spring Harbor by [Nobel laureate] Barbara Mc Clintock--to 'tag' the ramosa1 gene. That enabled us to isolate the gene and determine its DNA sequence for a variety of other experiments."

"As corn was being domesticated, farmers selected a larger and larger ear with more and more rows of kernels, based on the activity of genes other than ramosa1. But we suspect that as the ear got larger, it needed special alleles of ramosa1 to prevent the extra rows from forming branches instead of kernels," says Martienssen. "There may have been other reasons for selecting an unbranched ear, including the interaction with other genes that were subsequently lost during domestication, but we don't yet know if this is the case."

The study reveals that plants with more ramosa1 activity (e.g. typical corn) tend to have fewer branches, shorter branches, and fewer flowers whereas plants with less ramosa1 activity (e.g. sorghum, rice, and the ramosa corn variety described above) tend to have more branches, longer branches, and more flowers.

"We also looked at a popular ornamental grass that grows outside my office and found the same result. It has a spiky top like corn, so we were delighted to find that they have similar profiles of ramosa1 activity," says Martienssen.


'"/>

Source:


Related biology news :

1. Number Of Babies Born Prematurely Nears Historic Half Million Mark In U.S.
2. First Quantum Grant to fund stem cell repair of damage from stroke
3. Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Breakthrough Microarray-based Technology for the Study of Cancer
6. Nanogen Issued Patent for Electronic Microarray With Memory
7. Characterizing Skin Cancer by Microarrays
8. Microarrays as phenotype
9. Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research
10. Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible?status
11. Microarray technology for tailoring breast cancer therapy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/16/2016)... Dec 16, 2016 Research and Markets has ... - Global Forecast to 2021" report to their offering. ... The biometric vehicle ... at a CAGR of 14.06% from 2016 to 2021. The market ... projected to reach 854.8 Million by 2021. The growth of the ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
(Date:12/15/2016)... 2016  There is much more to innovative access ... engine. Continental will demonstrate the intelligence of today,s solutions ... . Through the combination of the keyless entry and ... elements, the international technology company is opening up new ... "The integration of biometric elements brings our ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... ... January 19, 2017 , ... ... pharmaceutical research and development (R&D), today announced the launch of Data ... interpretation for the rapidly evolving field of precision medicine. , Data ...
(Date:1/19/2017)... ... January 18, 2017 , ... The American Medical ... update its Data Sharing Policy. Specifically, the nation’s leading informatics experts, said data ... the existing policy. AMIA recommended that NIH earmark funding for researchers to produce ...
(Date:1/19/2017)... 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW ... therapies for operable and inoperable solid tumor cancers, announced ... Officer of NW Bio, will present at the Phacilitate ... the Hyatt Regency Hotel in Miami, Florida ... session entitled "New Therapeutic Approaches – Expanding the Reach ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, will feature ... compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, ... . Napabucasin is an orally-administered ... targeting STAT3. i Cancer stem cells (CSCs) possess ...
Breaking Biology Technology: